Telesis Bio Inc (TBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,783 | 23,532 | 30,594 | 24,916 | 22,282 |
| Marketable Securities | 747 | 8,710 | 13,159 | 25,014 | 39,607 |
| Receivables | 8,240 | 5,835 | 5,851 | 5,661 | 4,885 |
| Inventories | 3,861 | 2,294 | 2,200 | 2,195 | 1,776 |
| TOTAL | $61,543 | $42,939 | $55,092 | $62,185 | $72,027 |
| Non-Current Assets | |||||
| PPE Net | 7,557 | 7,256 | 6,861 | 6,291 | 6,306 |
| Intangibles | 16,511 | 16,640 | 16,768 | 16,897 | 16,470 |
| Other Non-Current Assets | 28,915 | 22,327 | 2,641 | 2,769 | 2,481 |
| TOTAL | $52,983 | $46,223 | $26,270 | $25,957 | $25,257 |
| Total Assets | $114,526 | $89,162 | $81,362 | $88,142 | $97,284 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,430 | 2,439 | 1,295 | 1,617 | 3,870 |
| Accrued Expenses | 3,788 | 3,297 | 5,858 | 4,529 | 3,999 |
| Other current liabilities | 361 | 434 | 373 | 480 | 469 |
| TOTAL | $10,386 | $11,240 | $13,498 | $12,808 | $18,244 |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,873 | 19,755 | 19,649 | 19,470 | 10,712 |
| Deferred Revenues | 2,173 | 2,975 | 3,958 | 4,191 | 4,086 |
| Other Non-Current Liabilities | 56,171 | 21,384 | 1,478 | 1,570 | 1,361 |
| TOTAL | $76,224 | $41,303 | $21,299 | $22,026 | $14,320 |
| Total Liabilities | $86,610 | $52,543 | $34,797 | $34,834 | $32,564 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,665 | 1,651 | 1,648 | 1,641 | 1,641 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -133,147 | -124,860 | -113,741 | -105,609 | -93,295 |
| Other shareholders' equity | 0 | 2 | -3 | -20 | -34 |
| TOTAL | $27,916 | $36,619 | $46,565 | $53,308 | $64,720 |
| Total Liabilities And Equity | $114,526 | $89,162 | $81,362 | $88,142 | $97,284 |